Proactive Investors - Run By Investors For Investors

PreveCeutical Medical Inc. receives first cannabis shipment at Australia lab

PreveCeutical Medical Inc. (CSE:PREV, OTCMKTS:PRVCF) CEO Stephen Van Deventer tells Proactive Investors the health sciences company received its first shipment of dried cannabis flowers and oils from Aurora Cannabis to their lab in Australia.

Van Deventer says PreveCeutical are now profiling three different cannabis strains for the application of soluble gel (Sol-gel) drug-delivery technology to cannabinoids. Van Deventer says it will take about 18 months until a product is available.

View full PREV profile View Profile

PreveCeutical Medical Inc Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use